Gennao Bio
Pennington, US · Founded 2020 · Delaware corporation · 1 known investors
Find your way into Gennao Bio
549 people in our graph share verified history with the Gennao Bio team — schools, employers, funds. One of them is your warm intro.
Steven Lambertunlockedknows Chris Duke · together at The Wharton School (overlapped)
knows the team · via The Wharton School
×2knows the team · via UC San Diego
knows the team · via The Ohio State University Moritz College of Law
knows the team · via Gennao Bio
×3knows the team · via The Ohio State University Fisher College of Business
Founders & leadership
CD
Chris DukeinChief Executive Officer2022–2025Chief Operating Officer of Gennao Bio, Chris Duke brings 15 years of experience in rare diseases and immuno-oncology spanning development and commercialization, including six years of global commercial leadership across North America, Europe, and Asia-Pacific, as well as clinical development oversight for immuno-oncology programs.
DL
Dale LudwiginMr. Ludwig is the Chief Scientific Officer
AG
Anuj GoswamiinGeneral Counsel2021–2025General Counsel and Secretary at Gennao Bio, where he has overseen equity financings and established governance and intellectual property frameworks. Goswami has served on the board of Suvoda LLC and provided advisory services on large debt finance transactions.
CP
Claudine ProwseinChief Financial Officer2021–2023She previously held CFO and operating roles at several biotech firms including Biogen, Human Genome Sciences, Rocket Pharma, and Ionis Pharmaceuticals, and holds a Ph.D. in Biochemistry from UC San Diego and a B.S. in Bioengineering from UCSD.
GS
Gary SenderNamed on SEC filing
JH
Julie HambletonNamed on SEC filing
BT
Bruce TurnerNamed on SEC filing
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$47.5M disclosed across 2 rounds · 2021–2022
▶$15MraisedDec 2022 · 3 investors · BiotechnologyRule 506(b)
▶$15MraisedDec 2022 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Julie HambletonDirector
- Anuj GoswamiExecutive Officer
- Claudine ProwseExecutive Officer
- Joe McIntoshExecutive Officer
- Bradley CampbellDirector
- Craig GordonDirector
- Stephen SquintoExecutive Officer, Director, Promoter
- Peter ThompsonDirector
- Dale LudwigExecutive Officer
- Chris DukeExecutive Officer
- Gary SenderDirector
- Offering amount
- $40M
- Amount sold
- $15M
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$32.5MraisedDec 2021 · 7 investors · BiotechnologyRule 506(b)
▶$32.5MraisedDec 2021 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Chris DukeExecutive Officer
- Chau KhuongDirector
- Gary SenderDirector
- Stephen SquintoExecutive Officer, Director, Promoter
- Dale LudwigExecutive Officer
- Julie HambletonDirector
- Anuj GoswamiExecutive Officer
- Claudine ProwseExecutive Officer
- Bruce TurnerDirector
- Offering amount
- $55M
- Amount sold
- $32.5M
- First sale
- May 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Gennao Bio's investors?
- Gennao Bio's investors include OrbiMed.
- How much funding has Gennao Bio raised?
- Gennao Bio has disclosed $47.5M raised across 2 rounds.
- Where is Gennao Bio headquartered?
- Gennao Bio is headquartered in Pennington, US.